BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $441,000 | +11.9% | 6,699 | -14.2% | 0.17% | +21.7% |
| Q2 2022 | $394,000 | -20.6% | 7,809 | +0.5% | 0.14% | -10.4% |
| Q1 2022 | $496,000 | -41.0% | 7,769 | -0.9% | 0.15% | -30.0% |
| Q4 2021 | $840,000 | +5.1% | 7,839 | +0.9% | 0.22% | +0.9% |
| Q3 2021 | $799,000 | +14.1% | 7,769 | -2.4% | 0.22% | +10.1% |
| Q2 2021 | $700,000 | -14.7% | 7,959 | -5.7% | 0.20% | -21.4% |
| Q1 2021 | $821,000 | -6.2% | 8,439 | +8.2% | 0.25% | -8.4% |
| Q4 2020 | $875,000 | +21.7% | 7,799 | +0.5% | 0.28% | +4.2% |
| Q3 2020 | $719,000 | +36.4% | 7,759 | +14.8% | 0.26% | +26.3% |
| Q2 2020 | $527,000 | – | 6,760 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |